Targeted therapy is a type of cancer treatment that targets specific molecules or pathways that are involved in the growth and spread of cancer cells. Here are some examples of targeted therapy medications that may be used for the treatment of liver cancer:

• Sorafenib:
  Sorafenib is a targeted therapy drug that works by blocking the signals that cancer cells use to divide and grow. It can be used to treat advanced liver cancer that cannot be removed with surgery.
• Lenvatinib:
  Lenvatinib is a targeted therapy drug that works by blocking the signals that cancer cells use to divide and grow. It can be used to treat advanced liver cancer that cannot be removed with surgery.
• Regorafenib:
  Regorafenib is a targeted therapy drug that works by blocking the signals that cancer cells use to divide and grow, as well as by blocking blood vessels that supply the tumor with nutrients. It can be used to treat advanced liver cancer that has progressed despite treatment with other medications.
• Cabozantinib:
  Cabozantinib is a targeted therapy drug that works by blocking the signals that cancer cells use to divide and grow, as well as by blocking blood vessels that supply the tumor with nutrients. It can be used to treat advanced liver cancer that has progressed despite treatment with other medications.

It’s important to note that the use of targeted therapy medications in the treatment of liver cancer is highly individualized, and the specific medications and treatment plan will depend on the stage and type of the cancer, as well as the individual patient’s needs. A healthcare provider will determine the most appropriate treatment plan for each patient.

Immunotherapy drugs are a type of cancer treatment that work by boosting the immune system to help it recognize and attack cancer cells. They are often used in the treatment of lung cancer, especially in cases where other treatments such as chemotherapy or radiation therapy have not been effective.

Some common immunotherapy drugs used in the treatment of lung cancer include:

• Programmed cell death protein 1 (PD-1) inhibitors: Pembrolizumab Nivolumab
• Programmed cell death ligand 1 (PD-L1) inhibitors: Atezolizumab | Durvalumab
• Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitors: Ipilimumab

Immunotherapy drugs are typically given by intravenous infusion and can be used alone or in combination with other treatments such as chemotherapy or radiation therapy. They are often used to treat advanced stage non-small cell lung cancer (NSCLC). The specific immunotherapy drug or combination of drugs used will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Hormone therapy drugs may be used to treat liver cancer that is caused by hormonal imbalances. For example, liver cancer caused by an excess of male hormones may be treated with drugs that block the production of these hormones.